Conducted by members of the Eliptica team, the study uses plasma proteomics across nutritional intervention studies to distinguish short-term dietary responses from more stable circulating-protein signals. The findings are directly relevant to population-scale biomarker discovery, where separating transient physiological effects from persistent disease-associated signals is essential for robust interpretation.